Buchang Pharma
步长制药
MedTech, BioTech & PharmaXi'an · Northwest (Shaanxi · Ningxia)
Business focus
MedTech, BioTech & Pharma
Description
Buchang Pharma (Shandong Buchang) was founded in 1993 by Zhao Buchang, growing from Shaanxi roots into a Heze, Shandong-headquartered TCM injectable-drug maker; its Danhong Injection (launched 2004) and Naoxintong Capsule became flagship cardiovascular products. FY2018 revenue was about CNY 13.7 billion against roughly CNY 8 billion in sales expenses — a ratio widely criticized in Chinese media; FY2024 revenue was reported around CNY 12.6 billion. Chairman Zhao Tao drew public scrutiny in 2019 after reports he paid $6.5 million to a US college-admissions consultant for his daughter.